| 000 | 01468 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250518052906.0 | ||
| 264 | 0 | _c20200622 | |
| 008 | 202006s 0 0 eng d | ||
| 022 | _a1756-8927 | ||
| 024 | 7 |
_a10.4155/fmc-2018-0512 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _adas Neves, Gustavo Machado | |
| 245 | 0 | 0 |
_aTargeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery. _h[electronic resource] |
| 260 |
_bFuture medicinal chemistry _c08 2019 |
||
| 300 |
_a2107-2130 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntiprotozoal Agents _xchemistry |
| 650 | 0 | 4 | _aDrug Discovery |
| 650 | 0 | 4 |
_aFolic Acid Antagonists _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeishmania _xdrug effects |
| 650 | 0 | 4 |
_aLeishmaniasis _xdrug therapy |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMultienzyme Complexes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aOxidoreductases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aTetrahydrofolate Dehydrogenase _xmetabolism |
| 650 | 0 | 4 |
_aThymidylate Synthase _xantagonists & inhibitors |
| 700 | 1 | _aKagami, Luciano P | |
| 700 | 1 | _aGonçalves, Itamar L | |
| 700 | 1 | _aEifler-Lima, Vera L | |
| 773 | 0 |
_tFuture medicinal chemistry _gvol. 11 _gno. 16 _gp. 2107-2130 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4155/fmc-2018-0512 _zAvailable from publisher's website |
| 999 |
_c29964672 _d29964672 |
||